Search results
Nationwide spice recall update as FDA issues concern level
Newsweek· 2 hours agoSeveral brands, produced by various manufacturers, were caught up in the recall published by the...
FDA’s call for innovation: AI-driven solutions for Parkinson’s freezing of gait detection and...
Medical Device Network via Yahoo Finance· 4 hours agoAs digital health technologies proliferate, the US Food and Drug Administration (FDA) is taking a...
FDA Approves Feed Ingredient to Cut Dairy Cow Methane Emissions
Bloomberg· 3 hours agoHave a confidential tip for our reporters? Elanco Animal Health Inc. received approval from the US...
Opinion | Want the best sunscreens this Memorial Day? The FDA is blocking you.
MSNBC via Yahoo News· 17 hours agoAmericans visiting beaches in France, Spain or Italy can do something that’s illegal back home:...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 5 hours agoThe US Food and Drug Administration (FDA) has accepted for priority review Sanofi's supplemental...
FDA considers weekly insulin for diabetics - ABC Columbia
ABC Columbia· 16 hours agoA U.S. Food and Drug Administration Advisory Committee is considering the benefits of a weekly...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Pharmaceutical Technology via Yahoo Finance· 43 minutes agoASP-1929 received fast track designation from the US Food and Drug Administration (FDA) in 2018. It...
AstraZeneca-Daiichi's Enhertu follow-up unable to prove overall survival benefit in phase 3
FierceBiotech· 3 hours agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
Chinese firm addressing FDA concerns over Durham facility - Triangle Business Journal
The Business Journals· 4 hours agoCARsgen Therapeutics has responded to observations made by the U.S. Food and Drug Administration...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 23 hours agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...